-
- Posted Tuesday October 29, 2013
stepNout Run/Walk/Dash aims at $1 million for TGen research
Nov. 3 event at Tempe Kiwanis Park benefits pancreatic cancer patients
TEMPE, Ariz. - Oct. 29, 2013 - The 8th annual
stepNout Run/Walk/Dash continues a march toward the $1 million mark
in fundraising for pancreatic cancer research at the Translational
Genomics Research Institute (TGen).
Registration begins at 7 a.m., opening ceremonies are set for 8:45
a.m., and races - including a 5K run - start at 9 a.m. on Nov. 3 at
Tempe's Kiwanis Park, 6111 S. All-America Way. Nearly 1,000
participants are expected again this year.
Vowing to "fight pancreatic cancer, one step at a time,"
organizers have set a goal to eventually surpass the $1 million
mark in fundraising. Participants in stepNout have donated more
than $600,000 since the event started in 2006.
This year's stepNout emcee will be ABC15 News Emmy-award-winning
journalist and cancer survivor Amy Murphy.
Also this year, stepNout will finish with a family carnival,
including a zip-line.
Among the ways to raise funds, supporters can purchase $5 raffle
tickets (5 for $20) for a chance to win a $1,000 VISA gift card.
Raffle tickets are available at www.helptgen.org.
Winner does not need to be present and will be notified by phone.
Every dollar raised through this promotion brings us one step
closer to a cure.
Participants also can join a team, sponsor a runner, or simply
make a donation. Online registration ends today (Oct. 29). You may
still register at the event, starting at 7 a.m.
One of TGen's goals is to develop a method of early detection for
pancreatic cancer. Currently, there are no tests to catch this
disease in its early stages. As a result, it is often not diagnosed
until its late stages, making it difficult to treat. More than
45,000 Americans will be diagnosed with pancreatic cancer this
year, and more than 38,000 will die from this disease, which kills
74 percent of those diagnosed within the first year. Only 6 percent
survive more than five years. The pancreas is a gland behind the
stomach that secretes enzymes into the small intestine to help
digestion and produce hormones.
TGen Foundation President Michael Bassoff said that each year the
stepNout event enables thousands of people to join TGen's fight
against pancreatic cancer.
"Our research team's recent success can be traced to the thousands
of patients and friends who participate in this event each year. We
expect the largest event in our history and trust that the research
team will use these funds to continue their incredible progress,"
Bassoff said.
November is national Pancreatic Cancer Awareness Month, a special
time for TGen's National Pancreatic Cancer Committee as it marks 8
years of making a difference in the lives of those battling the
nation's fourth leading cause of cancer death.
*
If you go to stepNout
What: The Translational Genomics Research
Institute's (TGen's) 8th annual stepNout Run/Walk/Dash, benefiting
TGen pancreatic cancer research.
Where: The south end of Tempe's Kiwanis Community
Park, 6111 S. All-America Way, Tempe. Enter off Guadalupe Road at
All American Way, between Rural and Kyrene roads.
When: 7-11 a.m. Sunday, Nov. 3.
Registration starts at 7 a.m.; races begin at 9 a.m.; an awards
ceremony is set for 10 a.m.; and a kids' dash is planned for 10:30
a.m.
Cost: Registration fees range from $15 to $35,
depending on age and competition. Children ages 4 and under are
free.
Registration: You can register at the event, or
register online by Oct. 29 by visiting www.tgenfoundation.org
and clicking the stepNout icon.
Parking: Parking is available along All-American
Way and surrounding lots.
Why: Organizers hope to raise more than $100,000
for TGen pancreatic cancer research.
# # #
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contacts:
Erin Massey
Vice President of Development, Cancer Programs
TGen Foundation
602-343-8470
[email protected]
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
